Schedule 13D ownership disclosure

PROGENICS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 743187106

Event date: 2019-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-098543
Form type
SC 13D
Filer
Altiva Management Inc.
CIK
CIK 1772491
Filed
Apr 05, 2019
Reporting period
Mar 27, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub